Company:  PDL BIOPHARMA, INC. (PDLI)
Form Type:  8-K
Filing Date:  5/22/2013 
CIK:  0000882104 
Address:  932 SOUTHWOOD BLVD 
City, State, Zip:  INCLINE VILLAGE, Nevada 89451 
Telephone:  775-832-8500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.42  
Change: 
-0.06 (-0.71%)  
Trade Time: 
Apr 24  
Market Cap: 
$1.35B
Description of Business
PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue. PDL is currently focused on intellectual property asset management, acquiring new income generating assets and maximizing value for its shareholders. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL was founded in 1986 and is headquartered in Incline Village, Nevada. In 2011, PDL initiated a strategy to bring in new income generating assets from the healthcare sector.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02 Departure of Directors or Certain Officers; ...
      Item 5.07 Submission of Matters to a Vote of Security Holders.
    SIGNATURES
BROKERAGE PARTNERS